Screening for Type 2 Diabetes

Summary and comment: Original articles: Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Spijkerman AMW, Adriaanse MC, Dekker JM, Nijpels G, Stehouwer CDA, Bouter LM, Heine RJ. Diabetes Care 2002; 25(10): 1784–9. Screening for Type 2 diabetes — should it be now? Borch-Johnsen K, Lauritzen T, Glumer C, Sandbaek A. Diabetic Med 2003; 20(3): 175–81.

[1]  A. Farmer.  The evidence base for diabetes care , 2004, ACP Journal Club.

[2]  M. Engelgau,et al.  The Evidence to Screen for Type 2 Diabetes Mellitus , 2003 .

[3]  Jaakko Tuomilehto,et al.  The diabetes risk score: a practical tool to predict type 2 diabetes risk. , 2003, Diabetes care.

[4]  Reporting diagnostic tests , 2003, BMJ : British Medical Journal.

[5]  D. Rennie,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.

[6]  W. Herman,et al.  A multivariate logistic regression equation to screen for diabetes: development and validation. , 2002, Diabetes care.

[7]  R. Colagiuri,et al.  The prevalence of diabetes in the kingdom of Tonga. , 2002, Diabetes care.

[8]  M. Jiwa,et al.  Screening for type 2 diabetes , 1998, Diabetes Care.

[9]  G. Roglić,et al.  Glucose intolerance and associated factors in Mongolia: results of a national survey , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[10]  S. Adjei,et al.  Diabetes in Ghana: a community based prevalence study in Greater Accra. , 2002, Diabetes research and clinical practice.

[11]  T. Dudley,et al.  Impact of diabetes screening on quality of life. , 2002, Diabetes care.

[12]  J. Dekker,et al.  Screening for Type 2 diabetes: an exploration of subjects' perceptions regarding diagnosis and procedure. , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[13]  Robert Atkins,et al.  The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. , 2002, Diabetes care.

[14]  S. Haffner,et al.  Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? , 2002, Annals of Internal Medicine.

[15]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[16]  D. Singer,et al.  The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. , 2001, The American journal of medicine.

[17]  T. Chen,et al.  A computer simulation model for cost-effectiveness analysis of mass screening for Type 2 diabetes mellitus. , 2001, Diabetes research and clinical practice.

[18]  P. O’Connor,et al.  Screening for diabetes mellitus in high-risk patients: cost, yield, and acceptability. , 2001, Effective clinical practice : ECP.

[19]  K Alich,et al.  Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. , 2001, Diabetes care.

[20]  H. Keen,et al.  Mortality and causes of death in the WHO multinational study of vascular disease in diabetes , 2001, Diabetologia.

[21]  V. Mohan,et al.  High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey , 2001, Diabetologia.

[22]  T. Buchanan,et al.  Protection from Type 2 Diabetes Persists in the TRIPOD Cohort Eight Months after Stopping Troglitazone , 2001 .

[23]  K. Narayan,et al.  Prevention of type 2 diabetes , 2001, BMJ : British Medical Journal.

[24]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[25]  N. Wareham,et al.  Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) , 2001, BMJ : British Medical Journal.

[26]  T. Tung,et al.  Evaluation of a population-based screening for type 2 diabetes: a community-based screening project in Puli, Taiwan. , 2000, Preventive medicine.

[27]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[28]  N. Wareham,et al.  Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice , 2000, Diabetes/metabolism research and reviews.

[29]  M. Fujishima,et al.  Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in a rural area of Japan. The Funagata diabetes study. , 2000, Journal of diabetes and its complications.

[30]  T Lauritzen,et al.  The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening , 2000, International Journal of Obesity.

[31]  C. Shaw,et al.  Psychological impact of predicting individuals' risks of illness: a systematic review. , 1999, Social science & medicine.

[32]  G. Riccardi,et al.  Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. , 1999, Diabetes care.

[33]  H. King,et al.  Pakistan National Diabetes Survey prevalence of glucose intolerance and associated factors in North West at Frontier Province (NWFP) of Pakistan. , 1999, JPMA. The Journal of the Pakistan Medical Association.

[34]  R. Gomis,et al.  The 1997 ADA diabetes diagnostic categories: impact on employees' annual medical examination. , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[35]  D. Schriger,et al.  Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. , 1999, JAMA.

[36]  S. Emmanuel,et al.  Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. , 1999, Diabetes care.

[37]  J. Gujral,et al.  Screening for Type 2 diabetes mellitus in the UK Indo‐Asian population , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[38]  A. Rosenbloom,et al.  Emerging epidemic of type 2 diabetes in youth. , 1999, Diabetes care.

[39]  R. Tresserras,et al.  Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. , 1999, Diabetes research and clinical practice.

[40]  B. Davis,et al.  Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. , 1998, Circulation.

[41]  A. Batieha,et al.  Diabetes and impaired glucose tolerance in Jordan: prevalence and associated risk factors , 1998, Journal of internal medicine.

[42]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[43]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[44]  J. Mold,et al.  Outcomes of an insurance company-sponsored multichannel chemistry screening initiative. , 1998, The Journal of family practice.

[45]  R. Hanson,et al.  Increasing prevalence of Type II diabetes in American Indian children , 1998, Diabetologia.

[46]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[47]  B. Keevil,et al.  Biological Variation of Glycated Hemoglobin: Implications for diabetes screening and monitoring , 1998, Diabetes Care.

[48]  T. Kitagawa,et al.  Increased Incidence of Non-Insulin Dependent Diabetes Mellitus Among Japanese Schoolchildren Correlates with an Increased Intake of Animal Protein and Fat , 1998, Clinical pediatrics.

[49]  N. Ray,et al.  Economic Consequences of Diabetes Mellitus in the U.S. in 1997 , 1998, Diabetes Care.

[50]  W. Tseng,et al.  Prevalence of diabetes mellitus and impaired glucose tolerance in Aborigines and Chinese in eastern Taiwan. , 1997, Diabetes research and clinical practice.

[51]  B. Balkau,et al.  Prevalence of NIDDM and impaired glucose tolerance in a rural and an urban population in Cameroon , 1997, Diabetologia.

[52]  Terje R Pedersen,et al.  Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.

[53]  R. Bain,et al.  Predictors of Progression From Impaired Glucose Tolerance to NIDDM: An Analysis of Six Prospective Studies , 1997, Diabetes.

[54]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[55]  Glycosuric tests should not be employed in population screenings for NIDDM. , 1997, Journal of public health medicine.

[56]  A. Farmer,et al.  Working together to reduce poverty's damage , 1997, BMJ.

[57]  B. Davis,et al.  Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.

[58]  Vic Hasselblad,et al.  A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. , 1996, JAMA.

[59]  C. Berne,et al.  A Population-Based Study of the Prevalence of Diabetes and Impaired Glucose Tolerance in Adults in Northern Sudan , 1996, Diabetes Care.

[60]  M. Engelgau,et al.  The Onset of NIDDM and its Relationship to Clinical Diagnosis in Egyptian Adults , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[61]  H. Valkenburg,et al.  Prevalence and Determinants of Glucose Intolerance in a Dutch Caucasian Population: The Hoorn Study , 1995, Diabetes Care.

[62]  G. Berglund,et al.  Fasting blood glucose in determining the prevalence of diabetes in a large, homogeneous population of Caucasian middle‐aged women , 1995, Journal of internal medicine.

[63]  M. Engelgau,et al.  Screening for Diabetes Mellitus in Adults: The utility of random capillary blood glucose measurements , 1995, Diabetes Care.

[64]  K Yoo,et al.  Prevalence of Diabetes and IGT in Yonchon County, South Korea , 1995, Diabetes Care.

[65]  S. Keinänen-Kiukaanniemi,et al.  Random capillary whole blood glucose test as a screening test for diabetes mellitus in a middle-aged population. , 1995, Scandinavian journal of clinical and laboratory investigation.

[66]  康生 大久保,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study , 1995 .

[67]  L. Franco,et al.  The ROC Curve in the Evaluation of Fasting Capillary Blood Glucose as a Screening Test for Diabetes and IGT , 1994, Diabetes Care.

[68]  Y. Akanuma,et al.  Prevalence of chronic complications in Japanese diabetic patients. , 1994, Diabetes research and clinical practice.

[69]  W. Newman,et al.  Community Screening for Diabetes: Low detection rate in a low-risk population , 1994, Diabetes Care.

[70]  M. Davies,et al.  Screening for Non-Insulin-Dependent Diabetes Mellitus (NIDDM): How Often Should it Be Performed? , 1994, Journal of medical screening.

[71]  D. Bell,et al.  Stroke in the diabetic patient. , 1994, Diabetes care.

[72]  K. Paterson.  Population Screening for Diabetes Mellitus , 1993 .

[73]  M. Davies,et al.  Community screening for non-insulin-dependent diabetes mellitus: self-testing for post-prandial glycosuria. , 1993, The Quarterly journal of medicine.

[74]  N. Levitt,et al.  The Prevalence and Identification of Risk Factors for NIDDM in Urban Africans in Cape Town, South Africa , 1993, Diabetes Care.

[75]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[76]  M. Rewers,et al.  Global Estimates for Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in Adults , 1993, Diabetes Care.

[77]  L. Niskanen,et al.  Lower-Extremity Amputations in Diabetic and Nondiabetic Patients: A population-based study in eastern Finland , 1993, Diabetes Care.

[78]  D. Simmons.  Screening for noninsulin dependent diabetes mellitus and impaired glucose tolerance in a Dunedin general practice--is it worth it? , 1992, The New Zealand medical journal.

[79]  R. Swaminathan,et al.  Assessment of Glucose Tolerance Test Criteria for Diagnosis of Diabetes in Chinese Subjects , 1992, Diabetes Care.

[80]  R. Klein,et al.  Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.

[81]  Validity of case-control studies and randomized controlled trials of screening. , 1991, International journal of epidemiology.

[82]  J. Trilling.  Screening for non-insulin-dependent diabetes mellitus. , 1988, Primary care.

[83]  N. Day,et al.  Case-control studies for the evaluation of screening. , 1986, Journal of chronic diseases.

[84]  John E. Shelton.  People's Republic of China , 1973 .

[85]  Dang Qing,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance The , 2022 .